Literature DB >> 29879270

Surrogate Markers and the Association of Low-Dose CT Lung Cancer Screening With Mortality.

Kaitlin M Woo1, Mithat Gönen1, Geoffrey Schnorr1, Gerard A Silvestri2, Peter B Bach2.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29879270      PMCID： PMC6145734          DOI： 10.1001/jamaoncol.2018.1263

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  6 in total

1.  Results of the Randomized Danish Lung Cancer Screening Trial with Focus on High-Risk Profiling.

Authors:  Mathilde M W Wille; Asger Dirksen; Haseem Ashraf; Zaigham Saghir; Karen S Bach; John Brodersen; Paul F Clementsen; Hanne Hansen; Klaus R Larsen; Jann Mortensen; Jakob F Rasmussen; Niels Seersholm; Birgit G Skov; Laura H Thomsen; Philip Tønnesen; Jesper H Pedersen
Journal:  Am J Respir Crit Care Med       Date:  2016-03-01       Impact factor: 21.405

2.  Surrogate endpoints in clinical trials: definition and operational criteria.

Authors:  R L Prentice
Journal:  Stat Med       Date:  1989-04       Impact factor: 2.373

3.  Survival of patients with stage I lung cancer detected on CT screening.

Authors:  Claudia I Henschke; David F Yankelevitz; Daniel M Libby; Mark W Pasmantier; James P Smith; Olli S Miettinen
Journal:  N Engl J Med       Date:  2006-10-26       Impact factor: 91.245

Review 4.  Benefits and harms of CT screening for lung cancer: a systematic review.

Authors:  Peter B Bach; Joshua N Mirkin; Thomas K Oliver; Christopher G Azzoli; Donald A Berry; Otis W Brawley; Tim Byers; Graham A Colditz; Michael K Gould; James R Jett; Anita L Sabichi; Rebecca Smith-Bindman; Douglas E Wood; Amir Qaseem; Frank C Detterbeck
Journal:  JAMA       Date:  2012-06-13       Impact factor: 56.272

5.  Reduced lung-cancer mortality with low-dose computed tomographic screening.

Authors:  Denise R Aberle; Amanda M Adams; Christine D Berg; William C Black; Jonathan D Clapp; Richard M Fagerstrom; Ilana F Gareen; Constantine Gatsonis; Pamela M Marcus; JoRean D Sicks
Journal:  N Engl J Med       Date:  2011-06-29       Impact factor: 91.245

6.  Lung cancer screening using low-dose computed tomography in at-risk individuals: the Toronto experience.

Authors:  Ravi J Menezes; Heidi C Roberts; Narinder S Paul; Maureen McGregor; Tae Bong Chung; Demetris Patsios; Gordon Weisbrod; Stephen Herman; Andre Pereira; Alexander McGregor; Zhi Dong; Igor Sitartchouk; Scott Boerner; Ming-Sound Tsao; Shaf Keshavjee; Frances A Shepherd
Journal:  Lung Cancer       Date:  2009-05-07       Impact factor: 5.705
  6 in total
  1 in total

1.  Effectiveness of Lung Cancer Screening Implementation in the Community Setting in the United States.

Authors:  Amy Copeland; Angela Criswell; Andrew Ciupek; Jennifer C King
Journal:  J Oncol Pract       Date:  2019-05-31       Impact factor: 3.840
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.